This case involves a patient who had a medical history of clotting issues who developed a hematoma on her upper right thigh. She presented to the hospital and was admitted with an elevated INR as well as swelling in the affected leg. The patient’s anticoagulation was stopped and vitamin K was given in order to stabilize her INR levels. While her INR was brought back into acceptable ranges, as well as the presence of other reassuring test results, anticoagulation was not resumed. However, doctors did choose to implant an IVC filter. A few weeks later the patient was killed by a massive pulmonary embolism.
Question(s) For Expert Witness
1. How is it determined if Coumadin should be re-started?
2. In a patient with this presentation, under what circumstances should the inferior vena cava be measured?
3. Can an IVC filter ever be used in place of anti-coagulation?
Expert Witness Response E-007690
In a patient with a history of venous thrombosis, Coumadin should be resumed as soon as the bleeding has stopped. Filters are placed to prevent pulmonary embolism, but do not prevent deep vein thrombosis. In this case the filter may have been tilted allowing a clot from the leg veins to go past the filter into the lungs, the filter may have been in a renal vein, or a clot could have been trapped in the filter and continued to grow on the upstream side of the filter and then broke off, going to the lungs. It is well recognized in the literature that pulmonary embolisms do occur after filter placement. The PREPIC study is the longest duration study showing this. The hospital records will display the size of the filter (it is most likely 30mm). It is not critical to measure the vena cava, since after deployment, the struts expand until they poke into the vena cava wall. Measuring the vena cava takes back seat to making sure the filter is in the vena cava and is properly oriented. Filters have been used to prevent pulmonary embolism for a limited time in patients who cannot be anticoagulated. Prolonged substitution for anticoagulation is not one of the indications for filters. Risks of filters include deep vein thrombosis, clogged filter, migrated filter, and fractures of the filter.
About the author
Joseph O'Neill
Joe has extensive experience in online journalism and technical writing across a range of legal topics, including personal injury, meidcal malpractice, mass torts, consumer litigation, commercial litigation, and more. Joe spent close to six years working at Expert Institute, finishing up his role here as Director of Marketing. He has considerable knowledge across an array of legal topics pertaining to expert witnesses. Currently, Joe servces as Owner and Demand Generation Consultant at LightSail Consulting.
